Tag: Dr

Dr. Reddy\’s Lab Q1 Results: Profit down 1% to Rs 1,392 crore but revenue jumps 14%

 stock analyst  07/28/2024  0 Comments on Dr. Reddy\’s Lab Q1 Results: Profit down 1% to Rs 1,392 crore but revenue jumps 14%

Dr. Reddy\’s Lab Q1 Results: While announcing the quarterly numbers, the company\’s board also approved split of equity shares in the ratio of 1:5, which means that 1 existing share will split into 5. The company said its revenue growth during the quarter was largely driven by growth in global generics revenues in North America as well as India.

Dr Reddy’s Laboratories board announces 1:5 stock split

 stock analyst  07/28/2024  0 Comments on Dr Reddy’s Laboratories board announces 1:5 stock split

Additionally the company has also announced that each American Depositary Share (ADS) will still represent 1 equity share. As a result, the number of ADSs held by each American Depositary Receipt holder will increase in proportion to the increase in equity shares.

Dr Lal PathLabs shares zoom 8% after Q4 results. Should you buy or sell?

 stock analyst  05/13/2024  0 Comments on Dr Lal PathLabs shares zoom 8% after Q4 results. Should you buy or sell?

Dr Lal PathLabs saw an 8% surge in shares to Rs 2,539.65 on the BSE following a 51% YoY increase in net profit to Rs 86 crore for Q4FY24. Analysts have varying opinions, with Kotak and JM Financial maintaining positive outlooks, while Goldman Sachs remains cautious.

Dr Lal PathLabs Q4 Results: Net profit rises 51% YoY to Rs 86 crore on improved volumes of diagnostic tests

 stock analyst  05/10/2024  0 Comments on Dr Lal PathLabs Q4 Results: Net profit rises 51% YoY to Rs 86 crore on improved volumes of diagnostic tests

Dr Lal PathLabs on Friday reported a 51% year-on-year (YoY) jump in net profit to Rs 86 crore in the quarter ended March 2024 led by improved volumes of diagnostic tests.

Dr Reddy’s shares tumble 5% as Q4 numbers fail to impress analysts. Should you buy, sell or hold?

 stock analyst  05/08/2024  0 Comments on Dr Reddy’s shares tumble 5% as Q4 numbers fail to impress analysts. Should you buy, sell or hold?

Dr Reddy’s Share Price: The company said that the jump in YoY net profit was largely driven by growth in global generics revenues in North America as well as emerging markets. DRL’s revenue also increased 12% YoY to Rs 7,083 crore.

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​